The identification of prognostic biomarkers and novel therapeutic targets in lung squamous cell carcinoma (SCC) is crucial. We analyzed the presence of the FGFR4-388Arg variant in 114 SCC patients and related it to increased MAPK signaling, and to reduced survival in lymph node-affected patients. These findings suggest that FGFR4 targeting in these patients may be a potential therapeutic strategy.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2q4gufo
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
To survive in its sand fly vector, the trypanosomatid protozoan parasite Leishmania first attaches to the midgut to avoid excretion, but eve...
-
Publication date: Available online 4 May 2017 Source: Journal of Dairy Science Author(s): V. Bonfatti, D. Vicario, A. Lugo, P. Carnier T...
-
The pursuit for clarity in diagnostic and treatment pathways for the complex, chronic condition of myalgic encephalomyelitis/chronic fatigue...
-
Background: Paget disease, Bowen disease, and malignant melanoma in situ are intraepidermal neoplasms, characterized by the presence of page...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oYRz8x via IFTTT
-
A new test, based on a patient's epigenetics, could be an accurate and inexpensive way to find and treat those at highest risk of anal c...
-
IJMS, Vol. 18, Pages 1591: The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer International Journal o...
-
Publication date: 30 August 2017 Source: Gene, Volume 626 Author(s): Ying-Hui Wang, Lin Fu, Bo Wang, Shu-Feng Li, Zhao Sun, Ying Luan At...
-
Purpose. To evaluate the diagnostic performance of the McMonnies questionnaire as a screening survey for dry eye in Chinese outpatients. Met...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου